跳至主要内容
临床试验/CTRI/2024/10/075329
CTRI/2024/10/075329尚未招募2/3 期

Randomised controlled clinical trial to compare the efficacy of khadireebeej churna with gokshura churna in the management of mootrashmari.

Tilak Ayurveda Mahavidyalaya1 个研究点 分布在 1 个国家目标入组 64 人开始时间: 2024年10月22日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
64
试验地点
1
主要终点
decrease in hematuria, abdominal pain, burning micturition and site of pain

研究概览

简要总结

The study will be intervened by the treatment of Khadireebeej Churna and Gokshura Churna to group A and group B respectively. The efficacy of the therapy will be assessed on the basis of subjective criteria for statistical analysis. Scoring will be designed according to the severity of symptoms. The subjective gradation of symptoms will be done as follows and the intensity of each symptom will be calculated before treatment, after treatment and after follow up. The effect of treatment result will be assessed in regards to clinical signs and symptoms on the basis of grading and scoring system. The signs and symptoms will be assessed by adopting the suitable scoring method.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Size of calculus- A known diagnosed case of renal calculus having calculus 6 to 8mm.

排除标准

  • Patient who are suffering from severe systemic disorders like renal failure,Carcinoma Known case of DM, HTN, Asthma, HIV, HbsAg. Congenital anomalies of kidney.
  • The pregnant women.

结局指标

主要结局

decrease in hematuria, abdominal pain, burning micturition and site of pain

时间窗: 14 days

次要结局

  • decrease in hematuria, abdominal pain, burning micturition and site of pain(28 days)

研究者

发起方
Tilak Ayurveda Mahavidyalaya
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Shivam Sunil Upadhyay

Tilak Ayurved Mahavidyalaya

研究点 (1)

Loading locations...

相似试验